Skip to content

Coronary metabolic profiling in patients with angina with non-obstructive coronary artery disease

Coronary metabolic profiling in patients with angina with non-obstructive coronary artery disease - COMET-ANOCA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037077
Enrollment
26
Registered
2025-06-11
Start date
2025-11-10
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic coronary syndrome coronary microvascular disease I20 I25

Interventions

Group 1: Patients undergoing clinically indicated coronary angiography due to suspected coronary artery disease are prospectively enrolled in the study. Before catheterization, the following study-r

Sponsors

Katholisches Klinikum Bochum gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: In principle, a signed informed consent form is required for participation in the study. Furthermore: 1. Patients undergoing invasive coronary diagnostics (coronary angiography, coronary microcirculation testing, right heart catheterization) due to typical symptoms (angina pectoris or equivalent symptoms such as exertional dyspnea or chest tightness) and/or signs (e.g., non-invasive evidence of myocardial ischemia) suggestive of coronary artery disease.

Exclusion criteria

Exclusion criteria: 1. History of percutaneous coronary intervention (PTCA, PCI) or coronary artery bypass grafting (CABG). 2. Known advanced renal impairment (eGFR <30 ml/min according to CKD-EPI). 3. Known advanced hepatic dysfunction. 4. Active malignant disease and/or acute or chronic inflammatory or infectious disease. 5. Participation in other medical studies within the past 3 months. 6. Pregnancy. 7. Relevant anemia (Hb <12 g/dl).

Design outcomes

Primary

MeasureTime frame
Investigation of the coronary microvascular plasma metabolome at rest and during invasive microcirculation testing in patients with and without coronary microvascular dysfunction.

Secondary

MeasureTime frame
1. Immunophenotyping of peripheral venous blood and coronary blood at rest and during invasive microcirculation testing in patients with and without coronary microvascular dysfunction. 2. Investigation of the cell-free DNA profile in coronary and whole blood at rest and during invasive microcirculation testing in patients with and without coronary microvascular dysfunction.

Countries

Germany

Contacts

Public ContactArash Haghikia

Katholisches Klinikum Bochum gGmbH

arash.haghikia@klinikum-bochum.de+49 234 509 9

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026